HB816 would expand Hawaii’s emergency overdose response protocols by authorizing licensed and registered EMTs to administer buprenorphine after giving an opioid antagonist during an opioid overdose response. The bill is framed as a public health and emergency medical services measure intended to reduce withdrawal symptoms, improve patient cooperation, and create a bridge from field treatment to longer-term recovery services.
The bill also directs the Department of Health to adopt rules establishing standard protocols for opioid-related overdoses, including treating such overdoses as life-threatening emergencies comparable to heart attacks and strokes. Those rules would incorporate buprenorphine administration into EMS practice, coordinate transitions to hospitals and treatment providers, and support implementation through EMT training and coordination with EMS providers statewide. The bill’s effective date is set for July 1, 3000, which appears to function as a placeholder rather than a near-term implementation date.
Impact
HB816 would amend section 329E-3, Hawaii Revised Statutes, to expressly authorize EMTs to administer buprenorphine after an opioid antagonist has been used in an overdose event. It would also impose new duties on the Department of Health to promulgate rules, develop protocols, allocate training resources, and coordinate implementation with EMS providers. The practical effect would be to broaden prehospital overdose treatment options and formalize buprenorphine as part of the state’s emergency response framework for opioid overdoses.
Sentiment
The bill text reflects strongly supportive sentiment toward expanding overdose response tools, emphasizing the opioid crisis, the limitations of antagonist-only treatment, and the benefits of buprenorphine as a bridge to recovery. The findings cite examples from other states and present the proposal as a modernization of EMS practice aligned with national best practices. No committee transcripts or recorded votes were provided, so there is no additional evidence of opposition or support from the legislative record beyond the bill’s own framing.
Contention
The main policy issue is whether EMTs should be authorized to administer buprenorphine in the field after naloxone or another opioid antagonist, and whether the Department of Health should be required to build new protocols and training around that practice. Potential concerns implied by the bill’s findings include clinical side effects, implementation logistics, and the need for coordination with hospitals and treatment providers. Because no hearing transcripts or votes are available, no specific legislator, agency, or stakeholder objections can be identified from the record provided.